Patient voice — irritable bowel syndrome

What this layer is

A structured record of how people with IBS describe the condition, who organises on their behalf, and where those accounts can be read. It exists because IBS is defined by symptom report: the patient's account is not colour around the evidence, it is a substantial part of the evidence. Three findings from the wiki make that concrete — the patient–practitioner relationship raised adequate relief from 44% to 62% in a randomised trial (Kaptchuk 2008, PMID 18390493); enacted stigma is measurably higher toward IBS than toward inflammatory bowel disease or asthma in randomised vignettes (Taft 2017, PMID 27501483); and 38% of tertiary-care patients had contemplated suicide because of their bowel symptoms (Miller 2004, PMID 15625650).

Four files:

File	Contents
README.md	This file: method, ethics, scope, limits
organizations.md	Patient organisations worldwide, each verified by retrieving its own site during the build session, with URL and access date
themes.md	Thematic synthesis of patient-reported experience, each theme supported by ≥2 independent sources
sources.md	Annotated source list with an honest coverage-limits note

Method

1. Peer-reviewed qualitative and survey research was identified through the same live PubMed E-utilities searches used to build the wiki (2026-09-02). Search terms included irritable bowel syndrome combined with: qualitative study patient experience; stigma; patient priorities and educational needs; doctor–patient interaction; work productivity; suicidal ideation. Every PMID cited here was retrieved in that session.
2. Patient organisations were identified from published sources and from web search, then each was verified by retrieving its own website on 2026-09-02. Organisations whose sites could not be retrieved are recorded as not retrievable this session rather than described from secondary sources; where a secondary source (a search-result summary, or another organisation's directory) is the only evidence, that is stated in the row.
3. Themes were derived from the peer-reviewed qualitative literature first, then checked against what organisations themselves say patients need. A theme is included only where two or more independent sources support it.
4. Everything is reported in aggregate. No individual patient story is reproduced, summarised or linked.

Ethics rules observed

Per CONVENTIONS.md §3:

• Public sources only. Peer-reviewed publications and organisations' own public web pages. No social media posts, no forum threads, no comment sections, no patient stories from any source.
• Paraphrase by default. Direct quotation is limited to ≤15 words and only where the exact wording carries information a paraphrase would lose. Every quote is attributed to its source.
• No named private individuals. No patient names, ages, locations, occupations, or any combination of details that could identify a person. Public figures and organisational spokespeople may be named in their public capacity — in this layer, only Jeffrey Roberts, named as founder of the IBS Patient Support Group and World IBS Day on that organisation's own public "who we are" page.
• Aggregate reporting. Themes are described as patterns across studies and populations, with counts and proportions where the source provides them. Where a proportion comes from a small qualitative sample, the sample size is given so the reader can weight it.
• No clinical advice. Nothing here tells anyone what to do about their symptoms. This is a research knowledge base.

Scope

In scope: adult IBS. How the condition is experienced; the diagnostic and consultation experience; stigma and credibility; work and social impact; what patients say they want from clinicians and from research; who organises on patients' behalf and what they provide.

Out of scope: paediatric IBS (noted where a source is paediatric); inflammatory bowel disease, coeliac disease and other organic conditions except where patients' experience of being distinguished from them is the point; functional dyspepsia except as overlap; individual treatment testimony of any kind.

Known limits of this layer

• English-language sources dominate. The qualitative studies used here are from the UK, Sweden, the USA, Canada and Iran. There is one non-Anglophone European organisation record (Netherlands) and one German-language one; there is nothing from Africa, Latin America, South Asia or East Asia in the qualitative evidence base assembled here, despite IBS prevalence being measured in all of those regions (epidemiology-and-burden).
• Several organisation websites returned HTTP 403 to automated retrieval on 2026-09-02 and are recorded as such rather than described from memory or from third-party summaries alone.
• One prominent UK domain has changed hands. theibsnetwork.org resolved on 2026-09-02 to a cryptocurrency-casino review site, not to the IBS charity. This is recorded in organizations.md because a stale link in a knowledge base about a stigmatised condition is a real harm, not a formatting issue. The charity itself is independently verified as a registered UK charity through search results.
• Selection bias in the qualitative literature. Most participants were recruited from clinics or from existing patient cohorts, and most were women — 82% female in the expressive-writing study (Halpert 2011, PMID 21561228), 85% in the national educational-needs survey (Halpert 2007, PMID 17488254), 76% in ACTIB (Everitt 2019, PMID 30971419). Men with IBS are systematically under-represented in the patient-experience evidence.
• Recency. Two of the most-cited patient-perspective datasets here date from 2004–2011. No comparable recent national survey of patient knowledge and expectations was retrievable in this session's searches (searched 2026-09-02).

Compiled 2026-09-02.